Medeon Biodesign (TPEx:6499) said today that it agreed to sell its XPro suture-mediated vascular closure device to Terumo Corp. (TYO:4543) for $20 million up front, plus milestones. The XPro device is designed for vascular closure following transcatheter aortic valve replacement, endovascular aneurysm repair, thoracic endovascular aneurysm repair and percutaneous balloon aortic valvuloplasty procedures. Medeon said it plans […]
New Zealand OKs CE Mark trial for Medeon Biodesign’s XPro large-bore vascular closure device
Medeon Biodesign said today it won approval from the New Zealand Ministry of Health’s Health and Disability Ethics Committees to initiate a clinical trial of its XPro suture-mediated vascular closure device as it seeks CE Mark approval. The study will examine the safety and effectiveness of the XPro System in facilitating hemostasis in patients undergoing percutaneous […]
Medeon Biodesign wins FDA 510(k) for AbClose
Taiwanese medical device company Medeon Biodesign said yesterday that it won 510(k) clearance from the FDA for its AbClose laparoscopic port site closure device. The AbClose device is designed as a single use, disposable laparoscopic port site closure device designed to allow for secure single-operator suturing while limiting user variability. “AbClose is designed to reduce […]
MassDevice Network
@MassDevice
LinkedIn
YouTube